Table 3.
Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|
Variables | HR | 95% CI | P value | HR | 95% CI | P value | |
Age | |||||||
> 65 vs ≤ 65 years | 1.07 | 0.75-1.53 | 0.719 | ||||
Gender | |||||||
Male vs Female | 0.98 | 0.70-1.38 | 0.904 | ||||
Tumor site | |||||||
Rectum vs Colon | 1.21 | 0.83-1.77 | 0.312 | ||||
Tumor size | |||||||
≥ 5 vs < 5 cm | 1.48 | 1.04-2.11 | 0.029 | 1.33 | 0.92-1.93 | 0.126 | |
Histological subtype | |||||||
Adenocarcinoma vs others | 0.66 | 0.36-1.18 | 0.160 | ||||
Histological grage | |||||||
Poor vs Well/Moderate | 1.64 | 1.15-2.35 | 0.006 | 1.56 | 1.07-2.27 | 0.020 | |
Depth of tumor invasion | |||||||
T3+T4 vs T1+T2 | 3.03 | 1.90-4.85 | <0.001 | 1.77 | 1.08-2.91 | 0.023 | |
Lymph node metastasis | |||||||
Presence vs Adsence | 3.63 | 2.55-5.19 | <0.001 | 2.41 | 1.62-3.58 | <0.001 | |
Distant metastasis | |||||||
Presence vs Adsence | 5.81 | 3.96-8.54 | <0.001 | 3.32 | 2.18-5.05 | <0.001 | |
Serum CEA level | |||||||
≥ 10 vs < 10 ng/mL | 1.51 | 1.05-2.17 | 0.025 | 1.32 | 0.91-1.93 | 0.147 | |
GHRLOS expression | |||||||
Decreased vs Non-decreased | 2.16 | 1.50-3.11 | <0.001 | 1.96 | 1.34-2.86 | 0.001 |
HR, hazard ratio; CI, confidence interval; CEA, carcinoembryonic antigen.